Optimizing Insulin Pump Therapy: A Quality Improvement Project

The Diabetes Educator

Volumn 39, Issue 6, 2013, Pages 841-847

  Meade, Lisa T ^a,b   Rushton, Wanda E ^a  

^a Piedmont HealthCare ^*  (United States)

^b WINGATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; INSULIN;

ARTICLE; CONTACT DERMATITIS; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN INFUSION; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT COMPLIANCE; PATIENT EDUCATION; QUESTIONNAIRE; SELF CARE; TOTAL QUALITY MANAGEMENT; UNITED STATES;

DERMATITIS, CONTACT; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN INFUSION SYSTEMS; MALE; PATIENT COMPLIANCE; PATIENT EDUCATION AS TOPIC; QUALITY IMPROVEMENT; QUESTIONNAIRES; SELF CARE; SOUTHEASTERN UNITED STATES;

EID: 84887484877     PISSN: 01457217     EISSN: 15546063     Source Type: Journal    
DOI: 10.1177/0145721713504628     Document Type: Article

References (14)

1. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977-986.
2. UK Prospective Diabetes Study Group. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:854-865.
3. Weissberg-Benchell J, Antisdel-Lomaglio J, Seshadri R. Insulin pump therapy: a meta-analysis. Diabetes Care. 2003;26:1079-1087.
4. Pickup JC, Sutton AJ. Severe hypoglycemic and glycemic control in type 1 diabetes: meta-analysis of multiple daily injections compared with continuous subcutaneous insulin infusion. Diabet Med. 2008;25:765-774.
5. General Hospital and Personal Use Medical Devices Panel. Insulin Infusion Pumps: Panel Information. Washington, DC: US Food and Drug Administration; 2010.
6. Lenhard MJ, Reeves GD. Continuous subcutaneous insulin infusion: a comprehensive review of insulin pump therapy. Arch Intern Med. 2001;161:2293-2300.
7. Walsh J, Roberts R. Pumping Insulin: Everything You Need for Success on a Smart Pump. San Diego, CA: Torrey Pines Press; 2006.
8. Scheiner G, Sobel RJ, Smith DE et al. Insulin pump therapy: guidelines for successful outcomes. Diabetes Educ. 2009;35:29S-41S.
9. Laffel L. Sick-day management in type 1 diabetes. Endocrin Metab Clin. 2000;29:707-723.
10. Bode BW. Pumping Protocol: A Guide to Insulin Pump Therapy Initiation. Northridge, CA: Medtronic Diabetes; 2008.
11. Skyler JS, Ponder S, Kruger DF, Matheson D, Parkin CG. Is there a place for insulin pump therapy in your practice? Clin Diabetes. 2007;25:50-56.
12. Meadows KA. So you want to do research? Questionnaire design. Br J Community Nurs. 2003;8:562-570.
13. Hanas R, Lindgren F, Linblad B. A two year national population study of ketoacidosis in Sweden: predisposing conditions and insulin pump use. Pediatr Diabetes. 2009;10:33-37.
14. Grunberger G, Bailey TS, Cohen AJ et al. Statement by the American Association of Clinical Endocrinologists consensus panel on insulin pump management. Endocr Pract. 2010;16:747-762.